Market Overview:
The global neurotrophins market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of neurodegenerative diseases, rising geriatric population, and growing demand for neurotrophic factors for regenerative therapies. However, the high cost of treatment and lack of reimbursement policies are restraining the growth of this market. The nerve growth factor segment is expected to account for the largest share of the global neurotrophins market in 2018. This segment is driven by increasing research on nerve growth factors for treating neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. The brain-derived neurotrophic factor (BDNF) segment is projected to grow at a highest CAGR during the forecast period owing to its wide applicability in various neurological disorders such as Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s disease, and depression. In terms of application, the neurology segment accounted for majority share of global neurotrophins market in 2017 and it is projected to maintain its dominance during forecast period due to increasing incidence rateof neurological disorders across globe .
Product Definition:
Neurotrophins are a family of proteins that stimulate the growth and survival of nerve cells. They are important for the development and maintenance of the nervous system.
Nerve Growth Factor:
Nerve growth factor (NGF) is a peptide hormone that plays an important role in the pathophysiology of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and Huntington’s Chorea. Increasing prevalence of these diseases has led to a growing demand for drugs that can be used for their treatment. The introduction of new products in the market coupled with ongoing clinical trials for NGF therapeutics is expected to drive this market during the forecast period.
Brain-Derived Neurotrophic Factor:
Brain-derived neurotrophic factor (BDNF) is a protein that promotes the growth of nerve cells and helps in the regeneration of brain tissues. It is mainly produced in response to injury or damage to brain tissue.
Application Insights:
The other application segment accounted for the largest revenue share in 2017 and is expected to witness significant growth during the forecast period. Other applications include spinal cord injuries, stroke, traumatic brain injury, multiple sclerosis and others. The growing number of patients suffering from neurodegenerative diseases such as Parkinson¢â‚¬â„¢s disease and Alzheimer¢â‚¬â„¢s disease is anticipated to drive the demand for neurotrophins over the forecast period.
Alzheimer's disease was one of the leading application segments in 2017 owing to increasing prevalence rate coupled with high unmet medical needs regarding treatment of memory disorders among older population globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors responsible for its growth. In addition, growing research activities to identify novel targets and develop effective treatment options is expected to drive the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to rising disposable income resulting in improved healthcare facilities & infrastructure coupled with an increase in awareness regarding early diagnosis of neurodegenerative diseases such as Alzheimer's Disease (AD), Parkinson's Disease (PD) & Huntington's Chorea (HD). These conditions usually have few symptoms at first which makes it difficult for people affected by them to get diagnosed at a later stage resulting in huge economic losses due to premature death.
Growth Factors:
- Increasing research and development activities for the treatment of neurodegenerative diseases.
- Growing geriatric population base across the globe, which is susceptible to various neurological disorders.
- Rising prevalence of chronic pain conditions, such as cancer, arthritis, and migraine headaches that require neurotrophin therapy for relief.
- Increasing demand for regenerative medicines to treat nerve damage or injuries.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurotrophins Market Research Report
By Type
Nerve Growth Factor, Brain-Derived Neurotrophic Factor, Dehydroepiandrosterone Sulfate, Other
By Application
Alzheimer'S Disease, Amyotrophic Lateral Sclerosis, Parkinson'S Disease, Other
By Companies
Johnson＆Johnson, Lonza Groups, FibroGen, Scil Proteins GmbH, Merck Serono, Scil Proteins GmbH, PeproTech, GE Healthcare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Neurotrophins Market Report Segments:
The global Neurotrophins market is segmented on the basis of:
Types
Nerve Growth Factor, Brain-Derived Neurotrophic Factor, Dehydroepiandrosterone Sulfate, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Alzheimer'S Disease, Amyotrophic Lateral Sclerosis, Parkinson'S Disease, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson＆Johnson
- Lonza Groups
- FibroGen
- Scil Proteins GmbH
- Merck Serono
- Scil Proteins GmbH
- PeproTech
- GE Healthcare
Highlights of The Neurotrophins Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nerve Growth Factor
- Brain-Derived Neurotrophic Factor
- Dehydroepiandrosterone Sulfate
- Other
- By Application:
- Alzheimer'S Disease
- Amyotrophic Lateral Sclerosis
- Parkinson'S Disease
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurotrophins Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neurotrophins are proteins that help to promote the growth and survival of nerve cells. They play a role in the development and function of the nervous system, as well as in the healing process after an injury.
Some of the major companies in the neurotrophins market are Johnson＆Johnson, Lonza Groups, FibroGen, Scil Proteins GmbH, Merck Serono, Scil Proteins GmbH, PeproTech, GE Healthcare.
The neurotrophins market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neurotrophins Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neurotrophins Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neurotrophins Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neurotrophins Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neurotrophins Market Size & Forecast, 2018-2028
4.5.1 Neurotrophins Market Size and Y-o-Y Growth
4.5.2 Neurotrophins Market Absolute $ Opportunity
Chapter 5 Global Neurotrophins Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Neurotrophins Market Size Forecast by Type
5.2.1 Nerve Growth Factor
5.2.2 Brain-Derived Neurotrophic Factor
5.2.3 Dehydroepiandrosterone Sulfate
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Neurotrophins Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Neurotrophins Market Size Forecast by Applications
6.2.1 Alzheimer'S Disease
6.2.2 Amyotrophic Lateral Sclerosis
6.2.3 Parkinson'S Disease
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neurotrophins Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neurotrophins Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Neurotrophins Analysis and Forecast
9.1 Introduction
9.2 North America Neurotrophins Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Neurotrophins Market Size Forecast by Type
9.6.1 Nerve Growth Factor
9.6.2 Brain-Derived Neurotrophic Factor
9.6.3 Dehydroepiandrosterone Sulfate
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Neurotrophins Market Size Forecast by Applications
9.10.1 Alzheimer'S Disease
9.10.2 Amyotrophic Lateral Sclerosis
9.10.3 Parkinson'S Disease
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Neurotrophins Analysis and Forecast
10.1 Introduction
10.2 Europe Neurotrophins Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Neurotrophins Market Size Forecast by Type
10.6.1 Nerve Growth Factor
10.6.2 Brain-Derived Neurotrophic Factor
10.6.3 Dehydroepiandrosterone Sulfate
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Neurotrophins Market Size Forecast by Applications
10.10.1 Alzheimer'S Disease
10.10.2 Amyotrophic Lateral Sclerosis
10.10.3 Parkinson'S Disease
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Neurotrophins Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Neurotrophins Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Neurotrophins Market Size Forecast by Type
11.6.1 Nerve Growth Factor
11.6.2 Brain-Derived Neurotrophic Factor
11.6.3 Dehydroepiandrosterone Sulfate
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Neurotrophins Market Size Forecast by Applications
11.10.1 Alzheimer'S Disease
11.10.2 Amyotrophic Lateral Sclerosis
11.10.3 Parkinson'S Disease
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Neurotrophins Analysis and Forecast
12.1 Introduction
12.2 Latin America Neurotrophins Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Neurotrophins Market Size Forecast by Type
12.6.1 Nerve Growth Factor
12.6.2 Brain-Derived Neurotrophic Factor
12.6.3 Dehydroepiandrosterone Sulfate
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Neurotrophins Market Size Forecast by Applications
12.10.1 Alzheimer'S Disease
12.10.2 Amyotrophic Lateral Sclerosis
12.10.3 Parkinson'S Disease
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Neurotrophins Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Neurotrophins Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Neurotrophins Market Size Forecast by Type
13.6.1 Nerve Growth Factor
13.6.2 Brain-Derived Neurotrophic Factor
13.6.3 Dehydroepiandrosterone Sulfate
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Neurotrophins Market Size Forecast by Applications
13.10.1 Alzheimer'S Disease
13.10.2 Amyotrophic Lateral Sclerosis
13.10.3 Parkinson'S Disease
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neurotrophins Market: Competitive Dashboard
14.2 Global Neurotrophins Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson＆Johnson
14.3.2 Lonza Groups
14.3.3 FibroGen
14.3.4 Scil Proteins GmbH
14.3.5 Merck Serono
14.3.6 Scil Proteins GmbH
14.3.7 PeproTech
14.3.8 GE Healthcare
